Failure to detect amphetamine or 1-amino-3-phenylpropane in humans or rats receiving the MAO inhibitor tranylcypromine.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Affective Disorders

• Publication date

  2000-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0165-0327(99)00188-3PMID 11099737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection and quantitation of a ring-hydroxylated metabolite of the antidepressant drug tranylcypromine

  2005cited by this paper
• The GCMS analysis of tranylcypromine (Parnate) in a suspected overdose.

  1997cited by this paper
• One fatal and one nonfatal intoxication with tranylcypromine. Absence of amphetamines as metabolites.

  1996cited by this paper
• Akathisia and Restless Legs

  1996cited by this paper
• Clinical Advances in Monoamine Oxidase Inhibitor Therapies

  1996cited by this paper
• The American Psychiatric Press Textbook of Psychopharmacology

  1995cited by this paper
• MAOIs in the Contemporary Treatment of Depression

  1995cited by this paper
• Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences Clinical Psychiatry

  1994cited by this paper
• Is tranylcypromine really metabolized to amphetamine

  1992cited by this paper
• Enantiospecific high-performance liquid chromatographic assay with fluorescence detection for the monoamine oxidase inhibitor tranylcypromine and its applicability in pharmacokinetic studies.

  1992cited by this paper
• Electron-capture gas chromatographic procedure for simultaneous determination of amphetamine and N-methylamphetamine.

  1992cited by this paper
• Treatment of imipramine-resistant recurrent depression, IV: A double-blind crossover study of tranylcypromine for anergic bipolar depression.

  1992cited by this paper
• Is tranylcypromine really metabolized to amphetamine?

  1992cited by this paper
• The biotransformation of tranylcypromine by Cunninghamella echinulata.

  1991cited by this paper
• Tranylcypromine versus imipramine in anergic bipolar depression.

  1991cited by this paper
• Acute cardiovascular effects of tranylcypromine: correlation with plasma drug, metabolite, norepinephrine, and MHPG levels.

  1991cited by this paper
• Plasma Tranylcypromine: Relationship to Pharmacokinetic Variables and Clinical Antidepressant Actions

  1990cited by this paper
• Tranylcypromine addiction: a case report and review.

  1990cited by this paper
• High Dose Tranylcypromine Therapy for Refractory Depression

  1989cited by this paper
• Monoamine oxidase inhibitor withdrawal phenomena: symptoms and pathophysiology

  1988cited by this paper
• Pharmacokinetics of tranylcypromine in patients who are depressed: Relationship to cardiovascular effects

  1986cited by this paper
• Pharmacotherapy of affective disorders : theory and practice

  1985cited by this paper
• Monoamine oxidase inhibitors

  1984cited by this paper
• Kinetics of MAO inhibitors.

  1983cited by this paper
• A method for measurement of tranylcypromine in rat brain regions using gas chromatography with electron capture detection.

  1981cited by this paper
• A procedure for extraction and separation of phenethylamine, tyramine and octopamine.

  1980cited by this paper
• Monoamine Oxidase Inhibitors as Antidepressants

  1980cited by this paper
• Determination of tranylcypromine in human plasma and urine using high-resolution gas--liquid chromatography with nitrogen-sensitive detection.

  1980cited by this paper
• Effects of tranylcypromine stereoisomers on monamine oxidation in man.

  1980cited by this paper
• Tranylcypromine (‘Parnate’) overdose: measurement of tranylcypromine concentrations and MAO inhibitory activity and identification of amphetamines in plasma

  1979cited by this paper
• Determination of Serum and Urine Concentrations of Tranylcypromine by Electron-Capture Gas-Liquid Chromatography

  1977cited by this paper
• DRUG TREATMENT IN PSYCHIATRY.

  1964cited by this paper
• METABOLISM OF TRANYLEYPROMINE-C14 AND DL AMPHETAMINE-C14 IN THE RAT.

  1963cited by this paper

• Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data

  2026cites this paper
• The trace amine theory of spontaneous hypertension as induced by classic monoamine oxidase inhibitors

  2021cites this paper
• Comments on Chronic Fatigue Syndrome.

  2019cites this paper
• Discrimination Between Drug Abuse and Medical Therapy: Case report of a tranylcypromine overdose-related fatality.

  2017cites this paper
• Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release.

  2014cites this paper
• Withdrawal and Discontinuation Phenomena Associated with Tranylcypromine: A Systematic Review

  2013cites this paper
• Advances Pertaining to the Pharmacology and Interactions of Irreversible Nonselective Monoamine Oxidase Inhibitors

  2011cites this paper
• Measuring Endogenous 5-HT Release by Emission Tomography: Promises and Pitfalls

  2010influential citation
• Self-enucleation of one eye.

  2009cites this paper
• Ti: myths about monoamine oxidase inhibitors perpetuated.

  2009cites this paper
• Tranylcypromine

  2006cites this paper
• Effects of monoamine oxidase inhibitors on cocaine discrimination in rats

  2006cites this paper
• Pharmacotherapy of Depression

  2004cites this paper
• Monoamine oxidase inhibitors

  2004cites this paper
• Clinical Pharmacology and Therapeuticsof Antidepressants

  2004cites this paper
• [11C]‐DASB, a tool for in vivo measurement of SSRI‐induced occupancy of the serotonin transporter: PET characterization and evaluation in cats

  2003cites this paper